Parker J L, Keller R S, Behm L L, Adams H R
Dalton Research Center, University of Missouri, Columbia 65211.
Am J Physiol. 1990 Aug;259(2 Pt 2):H504-11. doi: 10.1152/ajpheart.1990.259.2.H504.
Although the opiate receptor antagonist naloxone (NAL) has been reported to improve in vivo systolic performance of the heart in different circulatory shock syndromes, the influence of this drug on intrinsic cardiac mechanical function during hypodynamic circulatory states is unknown. The present study was designed to determine the effects of in vivo NAL on contraction-relaxation properties of isovolumic left ventricular (LV) preparations isolated from guinea pigs 4 h after induction of gram-negative endotoxemia. Animals were given a 1 mg/kg ip injection of Escherichia coli endotoxin and immediately treated intravenously with either NAL (4 mg/kg iv bolus plus 4 mg.kg-1.h-1 infusion) or an equivalent volume of saline. Endotoxin produced significant reduction of LV contractile function in coronary-perfused hearts, a response unaffected by NAL therapy. For example, LV systolic pressure at approximately 10 mmHg end-diastolic pressure averaged 78 +/- 3 and 82 +/- 6 mmHg in hearts from saline and NAL control animals, respectively, but only 41 +/- 2 and 40 +/- 2 mmHg in endotoxin and endotoxin plus NAL groups, respectively. LV end-diastolic pressure-volume relationships in endotoxin hearts were shifted upward and to the left of controls in the direction of decreased diastolic compliance (P less than 0.05). Importantly, in vivo NAL prevented the endotoxin-induced decrease in LV compliance of the isolated heart preparations (P less than 0.05). Thus intrinsic cardiac complications of early (4 h) nonhypotensive endotoxemia included decreased diastolic compliance as well as diminished contractility of the left ventricle. Only the diastolic compliance changes were NAL responsive and therefore may involve endogenous opioid systems in their pathophysiological expression.
尽管据报道阿片受体拮抗剂纳洛酮(NAL)可改善不同循环性休克综合征中心脏的体内收缩功能,但该药物对低动力循环状态下心脏固有机械功能的影响尚不清楚。本研究旨在确定体内NAL对革兰氏阴性内毒素血症诱导4小时后从豚鼠分离的等容左心室(LV)制剂收缩-舒张特性的影响。给动物腹腔注射1mg/kg大肠杆菌内毒素,并立即静脉注射NAL(4mg/kg静脉推注加4mg·kg-1·h-1输注)或等量生理盐水。内毒素使冠状动脉灌注心脏的左心室收缩功能显著降低,这种反应不受NAL治疗的影响。例如,在生理盐水和NAL对照动物的心脏中,舒张末期压力约为10mmHg时的左心室收缩压平均分别为78±3和82±6mmHg,但在内毒素组和内毒素加NAL组中分别仅为41±2和40±2mmHg。内毒素心脏的左心室舒张末期压力-容积关系向上和向左移动,朝着舒张顺应性降低的方向偏离对照组(P<0.05)。重要的是,体内NAL可防止内毒素诱导的离体心脏制剂左心室顺应性降低(P<0.05)。因此,早期(4小时)非低血压性内毒素血症的心脏固有并发症包括舒张顺应性降低以及左心室收缩力减弱。只有舒张顺应性变化对NAL有反应,因此其病理生理表现可能涉及内源性阿片系统。